Kay Tetzlaff

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

Kevin R. Flaherty, Athol U. Wells, Vincent Cottin et al. · New England Journal of Medicine · 2019 · 2.2K citations · Full text

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

Oliver Distler, Kristin B. Highland, Martina Gahlemann et al. · New England Journal of Medicine · 2019 · 1.5K citations · Full text

Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD

H Magnussen, Bernd Disse, Roberto Rodríguez-Roisin et al. · New England Journal of Medicine · 2014 · 615 citations · Full text

Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial

Henrik Watz, Kay Tetzlaff, Emiel F.�M. Wouters et al. · The Lancet Respiratory Medicine · 2016 · 413 citations · Full text

Asthma, Wisdom Trial, Allergy +7

Tiotropium and olodaterol fixed-dose combination <i>versus</i> mono-components in COPD (GOLD 2–4)

Roland Buhl, François Maltais, R Abrahams et al. · European Respiratory Journal · 2015 · 319 citations · Full text